Literature DB >> 35513827

Correction to: Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages.

Paballo Nkone1, Shayne Loubser2, Thomas C Quinn3,4, Andrew D Redd3,4, Arshad Ismail2, Caroline T Tiemessen2, Simnikiwe H Mayaphi5,6.   

Abstract

Entities:  

Year:  2022        PMID: 35513827      PMCID: PMC9069713          DOI: 10.1186/s12985-022-01803-4

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


× No keyword cloud information.

Correction to: Virology Journal (2022) 19:56 10.1186/s12985-022-01772-8

Following publication of the original article [1], the authors informed us that many epitopes from Table 3 have gross alignment issues, which were probably caused by formatting of this table before publication. The correct table is given below.
Table 3

Frequently targeted Pol CTL epitopes and their predicted HLA alleles

HLA alleles in boldface are those that have been identified (reported) in South Africa or southern Africa [11,28–30]. Alleles underlined are those that were reported to be protective [11,28–29,49,50]. PR = protease; RT = reverse transcriptase; IN = integrase; HLA = human leukocyte antigen

Frequently targeted Pol CTL epitopes and their predicted HLA alleles HLA alleles in boldface are those that have been identified (reported) in South Africa or southern Africa [11,28-30]. Alleles underlined are those that were reported to be protective [11,28-29,49,50]. PR = protease; RT = reverse transcriptase; IN = integrase; HLA = human leukocyte antigen The original article has been corrected.
  1 in total

1.  Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages.

Authors:  Paballo Nkone; Shayne Loubser; Thomas C Quinn; Andrew D Redd; Arshad Ismail; Caroline T Tiemessen; Simnikiwe H Mayaphi
Journal:  Virol J       Date:  2022-03-28       Impact factor: 5.913

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.